Buscar
Mostrando ítems 1-9 de 9
Preprint
Unlike Chloroquine, mefloquine inhibits SARS-CoV-2 infection in physiologically relevant cells and does not induce viral variants
| Fecha del documento:
2021 | Derechos de autor:
open access
Preprint
The role of NSP6 in the biogenesis of the SARS-CoV-2 replication organelle
| Fecha del documento:
2022 | Derechos de autor:
open access
Preprint
Repurposing the Ebola and Marburg Virus Inhibitors Tilorone, Quinacrine and Pyronaridine: In vitro Activity Against SARS-CoV-2 and Potential Mechanisms - Short running title: Ebola SARS-CoV-2 inhibitors
| Fecha del documento:
2021 | Derechos de autor:
open access
Preprint
Non-permissive SARS-CoV-2 infection of neural cells in the developing human brain and neurospheres
| Fecha del documento:
2020 | Derechos de autor:
open access
Preprint
Non-permissive SARS-CoV-2 infection in human neurospheres (preprint)
| Fecha del documento:
2021 | Derechos de autor:
open access
Preprint
Atazanavir inhibits SARS-CoV-2 replication and pro-inflammatory cytokine production
| Fecha del documento:
2020 | Derechos de autor:
open access
Preprint
Human endogenous retrovirus K activation in the lower respiratory tract of severe COVID-19 patients associates with early mortality
| Fecha del documento:
2021 | Derechos de autor:
open access
Preprint
Atazanavir, Alone or in Combination with Ritonavir, Inhibits SARS-CoV-2 Replication and Proinflammatory Cytokine Production
| Fecha del documento:
2020 | Derechos de autor:
open access
Preprint
Combination of Antiviral Drugs to Inhibit SARS-CoV-2 Polymerase and Exonuclease as Potential COVID-19 Therapeutics
| Fecha del documento:
2021 | Derechos de autor:
open access